期刊文献+

冠心病介入治疗后t-PA和PAI及vWF:Ag活性变化

Study on Relationship Between Changes of Fibrinolytic Activity and Prognosis after Successful PTCA
下载PDF
导出
摘要 目的 对46例经皮腔内冠状动脉成形术(PTCA)成功患者进行6个月随访,通过t-PA活性(t-PA:A)、PAI活性(PAIs:A)、vW因子抗原(vWF:Ag)的检测以观察内皮细胞纤溶活力变化和患者预后的关系。方法 根据冠状动脉造影结果将患者分为无再狭窄组35例和再狭窄组11例。所有患者均在PTCA术前及术后1h、1月、3月、6月肘静脉抽血,检测t-PA:A、PAIs:A和vWF:Ag含量。 结果 再狭窄组血浆t-PA:A术后上升,随访中下降;PAIs:A呈上升趋势,无再狭窄组血浆t-PA:A水平在术后1h上升,且在以后随访中仍保持上升趋势,其PAIs:A逐步下降(P<0.05);二组相比,再狭窄组PAIs:A水平在术后3个月和6个月时分别比无再狭窄组增高48%和66%(P均<0.05)。vWF:Ag水平,无再狭窄组术后恢复至术前水平,而再狭窄组术后始终比术前增高。 结论 异常增高的PAIs:A及vWF:Ag水平对血管成形术后再狭窄,可能起重要作用。 Objective To analyse possible association between changes of fibrinolytic activity and restenosis after successful percutaneous transluminal coronary angioplasty (PTCA). Methods Forty-six patients with coronary heart disease undergoing PTCA were followed up with angiography during 6 months, and were devided into no-restenosis group(A) and restenosis group(B). The plasma t-PA : A, PAIs : A, and vWF; Ag levels of all patients were determined before PTCA and Ih, 1m, 3m, 6m after PTCA. Results The difference in plasma t-PA : A levels before and after PTCA between group A and B was not significant. The levels of plasma PAIs : A in group B at 3m, 6m after PTCA were higher than those in group A(P <0. 05). The levels of vWF : Ag at Ih after PTCA were increased in both groups, but were decreased in 6-month follow-up in group A,yet were still higher in group B than those in group A(P <0. 05). Conclusion The results indicate that abnormality of PAIs activity and vWF ? Ag may play an important role in restenosis after successful PTCA.
出处 《上海第二医科大学学报》 CSCD 2003年第3期240-242,共3页 Acta Universitatis Medicinalis Secondae Shanghai
关键词 冠心病 介入治疗 纤溶活性 再狭窄 vW因子抗原 内皮细胞 冠状动脉造影 percutaneous transluominal coronary angioplasty fibrinolytic activity vWF : Ag restenosis
  • 相关文献

参考文献4

  • 1Hillegass WB, Ohman EM, Califf RM. Restenosis: clinical issues[M].In: Topol EJ, editor. Textbook of interventional cardiology. Philadephia: WB Saunders, 1994. 415-435.
  • 2Forrester JS, Fishbein MC, Heifant RH, et al. A paradoa, for res tenosis based on cell biology: clues for the development of new prevent therapy[J]. J Am Coll Cardiol, 1991, 17: 758-762.
  • 3ECAT angina pectoris study group. ECAT angina pectoris study: baseline associations of haemostatic factors in 3000 patients with angina pectoris undergoing coronary arteriography[J]. Eur Heart J, 1993, 14: 8-13.
  • 4Haesenstab D, Forough R, Clowes AW. Plasminogen activator inhibitor type 1 and tissue inhibitor of metalloproteinases 2 intrease after arterial injury in rats[J]. Circ Res, 1997, 80: 490-493.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部